ERBB2 and breast carcinoma: As an example, targeting therapy of ERBB2, an important regulator of breast cancer, turns out to be not successful because of the co-amplification and over-expression of its neighbor genes (Vanden Bempt et al. 2007; Hu et al., 2009).